Downregulation of HOXC6 in serous ovarian cancer

Cancer Investigation

Volumn 33, Issue 7, 2015, Pages 303-311

  Tait, David L ^a   Bahrani Mostafavi, Zahra ^b   Vestal, C Greer ^c   Richardson, Christine ^c   Mostafavi, M Taghi ^b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b University of North Carolina at Charlotte   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Biomarker discovery; Homeobox genes; HOXC6; Serous ovarian cancer

Indexed keywords

HOX PROTEIN; HOXC6 PROTEIN; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; HOXC6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LASER CAPTURE MICRODISSECTION; OVARIAN CANCER CELL LINE; OVARIAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SEROUS OVARIAN CANCER; UPREGULATION; VERY ELDERLY; BLOOD; CYSTADENOCARCINOMA; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; METABOLISM; MIDDLE AGED; NEOPLASM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CYSTADENOCARCINOMA, SEROUS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS;

EID: 84947905245     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2015.1041641     Document Type: Article

References (51)

1. Siegel R,Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: Cancer J Clin 2014;64(1): 9-29.
2. Flemming G, Siedman, Ernst L. Epithelial ovarian cancer. In: Barakat R, Berchuck A, Markman M, Randall M, eds. Principles and Practice of Gynecologic Oncology, 6th ed. Philadelphia, PA: LippincottWilliams &Wilkins; 2013;757-847.
3. Fekete T, Raso E, Pete I, Tegze B, Liko I, Munkacsy G, Sipos N, Rigo J Jr., Gyorffy B. Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples. Int J Cancer 2012;131(1): 95-105.
4. Alexander T, Nolte C, Krumlauf R. Hox genes and segmentation of the hindbrain and axial skeleton. Annu Rev Cell Dev Biol 2009;25: 431-456.
5. Colleen D. McCabe, Demetri D. Spyropoulos, DavidMartin, and Carlos S. Moreno. Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer. Cancer Research The AJCR 2008: 1931-1940.
6. Calvo R, West J, Franklin W, Erickson P, Bemis L, Li E, Helfrich B, Bunn P, Roche J, Brambilla E, et al. Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A 2000;97(23): 12776-12781.
7. Flagiello D, Poupon MF, Cillo C, Dutrillaux B, Malfoy B. Relationship between DNA methylation and gene expression of the HOXB gene cluster in small cell lung cancers. FEBS Lett 1996;380(1-2): 103-107.
8. Hung YC, Ueda M, Terai Y, Kumagai K, Ueki K, Kanda K, YamaguchiH, Akise D, Ueki M. Homeobox gene expression andmutation in cervical carcinoma cells. Cancer Sci 2003;94(5): 437-441.
9. Lane DB, Rutherford TJ, Taylor HS. HOXA10 expression in endometrial adenocarcinoma. Tumour Biol 2004;25(5-6): 264-269.
10. Segara D, Biankin AV, Kench JG, Langusch CC, Dawson AC, Skalicky DA, Gotley DC, Coleman MJ, Sutherland RL, Henshall SM. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res 2005;11(9): 3587-3596.
11. Takahashi Y, Hamada J, Murakawa K, Takada M, Tada M, Nogami I, Hayashi N, Nakamori S, Monden M, Miyamoto M, Katoh H, Moriuchi T. Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Exp Cell Res 2004;293(1): 144-153.
12. Chariot A, Castronovo V, Le P, Gillet C, Sobel M, Gielen J. Cloning and expression of a new HOXC6 transcript encoding a repressing protein. Biochem J 1996;319: 91-97.
13. Bodey B, Bodey B Jr., Siegel SE, Kaiser HE. Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhoodmedulloblastomas/primitive neuroectodermal tumors. Anticancer Res 2000;20(3A): 1769-1780.
14. Villaescusa JC, Verrotti AC, Ferretti E, Farookhi R, Blasi F. Expression of Hox cofactor genes during mouse ovarian follicular development and oocyte maturation. Gene 2004;330: 1-7.
15. Bodey B, Bodey B Jr., Siegel SE, Kaiser HE. Immunocytochemical detection of the homeobox B3, B4, and C6 gene products within the human thymic cellular microenvironment. In Vivo 2000;14(3): 419-424.
16. Bill JJ, van Oostveen JW,Walboomers JM, Brink AT, Vos W, Ossenkoppele GJ, Meijer CJ. Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 inmyeloid leukemias and normal myeloid cells. Leukemia 1998;12: 1724-1732.
17. Garcia-Gasca A, Spyropoulos DD. Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice. Dev Dynam 2000;219: 261-276.
18. Kloen P, Visker MH, Olijve W, van Zoelen EJ, Boersma CJ. Celltype-specific modulation of Hox gene expression by members of the TGF-beta superfamily: A comparison between human osteosarcoma and neuroblastoma cell lines. Biochem Biophys Res Commun 1997;233(2): 365-369.
19. Ansari KI, Hussain I, Shrestha B, Kasiri S, Mandal SS. HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment. J Mol Biol 2011;411(2): 334-349.
20. Singleton DW, Feng Y, Yang J, Puga A, Lee AV, Khan SA. Gene expression profiling reveals novel regulation by bisphenol-A in estrogen receptor-alpha-positive human cells. Environ Res 2006;100(1): 86-92.
21. Kim KJ, Moon SM, Kim SA, et al. Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells. Oncogene 2013;32: 3339-3349.
22. Vinarskaja A, Yamanaka M, Ingenwerth M, Schulz WA. DNA methylation and the HOXC6 paradox in prostate cancer. Cancers (Basel) 2011;3(4): 3714-3725.
23. BodeyB, Bodey B Jr, Siegel SE, Luck JV,KaiserHE.HomeoboxB3, B4, and C6 gene product expression in osteosarcomas as detected by immunocytochemistry. Anticancer Res 2000;20(4): 2717-2721.
24. Castronovo V, Kusaka M, Chariot A, Gielen J, Sobel M. Homeobox genes: Potential candidates for the transcriptional control of the transformed and invasive phenotype. Biochem Pharmacol 1994;47(1): 137-143.
25. Fujiki K, Duerr EM, Kikuchi H, Ng A, Xavier RJ, Mizukami Y, Imamura T, Kulke MH, Chung DC. Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth. Gastroenterology 2008;135(3): 907-916, 916 e901-902.
26. Miller GJ,MillerHL, van Bokhoven A, Lambert JR,Werahera PN, Schirripa O, Lucia MS, Nordeen SK. Aberrant HOXC expression accompanies themalignant phenotype in human prostate. Cancer Res 2003;63(18): 5879-5888.
27. Moon SM, Kim SA, Yoon JH, Ahn SG. HOXC6 is deregulated in human head and neck squamous cell carcinoma and modulates Bcl-2 expression. J Biol Chem 2012;287(42): 35678-35688.
28. Bahrani-Mostafavi Z, Tickle TL, Zhang J, Bennett KE, Vachris JC, Spencer MD, Mostafavi MT, Tait DL. Correlation analysis of HOX, ErbB and IGFBP family gene expression in ovarian cancer. Cancer Invest 2008;26(10): 990-998.
29. Naora H, Montz FJ, Chai CY, Roden RB. Aberrant expression of homeobox gene HOXA7 is associated with mullerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response. Proc Natl Acad Sci U S A 2001;98(26): 15209-15214.
30. NaoraH, Yang YQ,Montz FJ, Seidman JD, Kurman RJ, Roden RB. A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci U S A 2001;98(7): 4060-4065.
31. Tickle TL. Data mining the serous ovarian tumor transcriptome. Charlotte: University of North Carolina; 2011.
32. Tsao SW, Mok SC, Fey EG, Fletcher JA,Wan TS, ChewEC, Muto MG, Knapp RC, Berkowitz RS. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res 1995;218(2): 499-507.
33. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3(6): 1101-1108.
34. Bahrani Z, Sherwood J, Sanborn M, Keyser G. The Use ofMonoclonal Antibodies to detect wheat soil-borne mosaic virus. J Gen Virol 1988;69: 1317-1322.6d
35. Eisenhart C.The assumptions underlying the analysis of variance. Biometrics 1947;3(1): 1-22.
36. Tamhane A, Dunlop D. Statistics and data analysis: From elementary to intermediate. Upper Saddle River, NJ: Prentice Hall; 2000.
37. Michael T. Furlong, Colleen D. Hough, Cheryl A. Sherman-Baust, Ellen S. Pizer, Patrice J. Morin. Available at http://jnci.oxfordjournals.org/content/91/15/1327.full.pdf
38. Steller MD, Shaw TJ, Vanderhyden BC, Ethier JF. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells. Mol Cancer Res 2005;3(1): 50-61.
39. Bai F, Feng J, Cheng Y, Shi J, Yang R, Cui H. Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potentials. Int J Gynecol Cancer 2006;16(1): 202-9.
40. Cheng W, Liu J, Yoshida H, Rosen D, Naora H. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med 2005;11(5): 531-537.
41. Tait D,McKinney K, Zhang J, Vachris JC, Gurlov S, Hall J, Higgins RM, Naumann R, Bahrani-Mostafavi Z. Up-regulation of HOXB7 gene in epithelial ovarian cancer. Proceedings of the Thirty-seventh annual meeting of the Society of Gynecologic Oncologists 2006, p. 106.
42. Tait D, Zhang J, Gurlov S, McKinney K, Vachris JC, Mongeot J, Wagstaff J, Bahrani-Mostafavi Z. Differential expression of HOX genes in ovarian cancer. Proceedings of the Ninety-sixth annual meeting of the American Association for Cancer Research 2005, 46: 845.
43. Ramachandran S, Liu P, Young AN, Yin-Goen Q, Lim SD, Laycock N, Amin MB, Carney JK, Marshall FF, Petros JA, et al. Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene 2005;24(1): 188-198.
44. Duverger O,MorassoMI. Role of homeobox genes in the patterning, specification, and differentiation of ectodermal appendages in mammals. J Cell Physiol 2008;216(2): 337-346.
45. Friedmann Y, Daniel CA, Strickland P, Daniel CW. Hox genes in normal and neoplastic mouse mammary gland. Cancer Res 1994;54(22): 5981-5985.
46. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474(7353): 609-615.
47. Tao Y, Xi S, Briones V,Muegge K. Lshmediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation. PLoS One 2010;5(2): E9163.
48. Markman M, Liu PY, Rothenberg MI, et al. Pre-treatment CA-125and risk of relapse in advanced ovarian cancer. J Clin Oncol 2006;24: 1454-1458.
49. Cheng X, Ye X, Dong L, et al.Human epididymis protein 4 (HE$) as a serum tumor biomarker in patients with ovarian cancer. Int J Gyncol Cancer 2011;21: 852-858.
50. Przybycin C, Kurman RJ, Ronnett BM, Shih I, Vang R. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Path 2010;34: 1407-1416.
51. Auersperg N. The origin of ovarian carcinomas. A unifying hypothesis. Int J Gynecol Path 2010;30: 12-21.